Introduction to Jun 26 2026 This Week In Cardiology
Exploring Jun 26 2026 This Week In Cardiology reveals several interesting facts. Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ...
Jun 26 2026 This Week In Cardiology Comprehensive Overview
Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the ... John Mandrola offers an ACC recap of 5 big trials—Hi-PEITHO, PROTAVI, ORBITA-CTO, CHIPS-BCIS3 and CHAMPION AF This ... PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA ...
Welcome to This
Summary & Highlights for Jun 26 2026 This Week In Cardiology
- A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in
- Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the ...
- Chemical cardioversion in the ED, HF monitoring, weight loss in AF, and surgical LAA excision are the topics John Mandrola, MD, ...
- Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, ...
- Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail ...
Stay tuned for more updates related to Jun 26 2026 This Week In Cardiology.